Developement and Evaluation of Serological Assays for COVID-19 (SEROCOV)

Assistance Publique - Hôpitaux de Paris

Status: Unknown

Conditions: COVID-19

Study type: Observational

Funder types: Other

Identifiers

NCT04377763

20MWI-SEROCOV

Details and patient eligibility

About

The primary objective of the study aims to evaluate serological assays of virus Covid-19.

Full description

This is a retrospective monocentric study, which will include the patients who have hospitalized in Ambroise Paré Hospital and have sampling sent to the Laboratory of Microbiology of the hospital between the 15 March 2020 and 30 september 2020.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient ≥ 18 years;
• Have molecular diagnosis of positive or negative result in Covid-19 virus by the Laboratory of Microbiology in Ambroise Paré Hospital;
• Have diagnosed of a viral infection in respiratory.

Exclusion criteria

• Patient refusal.